Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by gericon Jun 20, 2013 2:06pm

187 Views

Post# 21549255

RE: RE: RE: Two Variables

Then I congratulate you. If only everyone did this I wouldn't be seeing all these people in their 30s and 40s after their heart attacks. Your level of 150 (which is equivalent to 3.89 in Canadian readings) is very good but the important number is the HDL to determine your ratio which would be ideal if less than 3.

I have a TC of 4 with HDL of 1.9 just on diet and exercise but I'm in this business so I'm faced with the alternative everyday.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec